SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-21-107762
Filing Date
2021-04-06
Accepted
2021-04-06 17:22:36
Documents
3
Period of Report
2021-05-17

Document Format Files

Seq Description Document Type Size
1 DEF 14A d155968ddef14a.htm DEF 14A 331209
2 GRAPHIC g155968page038.jpg GRAPHIC 115342
3 GRAPHIC g155968page039.jpg GRAPHIC 105776
  Complete submission text file 0001193125-21-107762.txt   637180
Mailing Address 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET #455 EMERYVILLE CA 94608 5105052680
4D Molecular Therapeutics Inc. (Filer) CIK: 0001650648 (see all company filings)

IRS No.: 473506994 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39782 | Film No.: 21809993
SIC: 2836 Biological Products, (No Diagnostic Substances)